finance
Finance
Critical Metals partners with Romania's FPCU to set up rare earth processing plant
Finance
Oil settles down about 1% as traders focus on Ukraine peace talks, Fed policy decision
Finance
Trafigura lifts dividend payments in 2025 despite lower net profits
Headlines
Explainer-What happens if French social security bill fails
Exclusive-Top Indian arms makers held rare meetings in Russia on potential joint ventures, sources say
Date: December 9, 2025
By Shivam Patel NEW DELHI, Dec 9 (Reuters) - At least half a dozen executives from top Indian arms makers, including Adani Defence and Bharat Forge, attended rare meetings in Russia this year to...
COVID fraud inflicts 11 billion pound hit to UK public finances, report shows
Date: December 9, 2025
MANCHESTER, England, Dec 9 (Reuters) - Fraudulent claims for taxpayer funds during the COVID-19 pandemic cost Britain's public finances 10.9 billion pounds ($14.5 billion), the government said on...
'Shockingly high' number of Gaza children still acutely malnourished after truce, UN says
Date: December 9, 2025
GENEVA, Dec 9 (Reuters) - Thousands of children have been admitted for treatment for acute malnutrition in Gaza since an October ceasefire that was supposed to enable a major increase in humanitarian...
EU's Kallas says criticism of liberties in Europe should be aimed elsewhere, 'Russia perhaps'
Date: December 9, 2025
BRUSSELS, Dec 9 (Reuters) - European Union foreign policy chief Kaja Kallas said on Tuesday that criticism of liberties in the bloc should be aimed elsewhere and at "Russia perhaps", referring to a...
Japan denies report it rebuffed EU's plea to join Russian asset plans
Date: December 9, 2025
TOKYO, Dec 9 (Reuters) - Japan's government on Tuesday denied a media report that it had rebuffed a European Union request over plans to use frozen Russian state assets to fund Ukraine. "It's...
Exclusive-US FDA launches fresh safety scrutiny of approved RSV therapies for infants
Date: December 9, 2025
By Dan Levine and Patrick Wingrove Dec 9 (Reuters) - U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for...